Bivalent COVID-19 Vaccine OK’d for Ages 5–11

Bivalent COVID-19 Vaccine OK’d for Ages 5–11

Centers for Disease Control and Prevention Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo expanding the use of updated (bivalent) COVID-19 vaccines to children ages 5 through 11 years. This follows the Food and Drug Administration’s (FDA)...